I have no idea, but this part of the last PR intri
Post# of 5066
"We plan to in-license the patent portfolio in Q2 of 2013 and establish collaborations with academic and industry groups to file an IND by Q4 of 2013."
I have never really seen anyone dwell on that part of the PR.
I'm wondering if its safe to postulate a possible JV, or outside
funding by, dare I say it, a big pharma entity. who knows, lets hope so.
Im thinking we can expect some kind of news this Quarter.
but again, what do I know?
happy trading